MMMaría Luz Amador Muñoz

María Luz Amador Muñoz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


María Luz Amador Muñoz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The influence of social media and video-on-demand platforms on the appeal and consumption of tobacco and emerging tobacco products: A cross-sectional study

    by Diego de Haro, Maria Luz Amador, Mario Lopez-Salas, Karen L. Ramirez Cervantes, Antonio Yanes-Roldan, Belén Fernández, Jose M. Martin-Morero

    Introduction: Digital platforms serve as an avenue for the tobacco industry to promote both conventional tobacco and emerging products, with a notable focus on capturing the attention of young people through sophisticated marketing campaigns. This research aims to analyze the prevalence of...


  • Open Access

    Knowledge, Compliance, and Inequities in Colon Cancer Screening in Spain: An Exploratory Study

    by Mario López Salas, Diego De Haro Gázquez, Belén Fernández Sánchez, María Luz Amador Muñoz

    In Spain, inequities exist in implementing colorectal cancer (CRC) tests with the target population—adults aged 50 to 69—as part of population-based CRC screening programs. This research aims to further our understanding of the target population’s awareness, attitudes, and perceptions of these test-based screening programs. A survey was carried out using an online panel representative of the target population, with a sample collected from 5313 individuals. Data collection took place in June 2022. Descriptive and bivariate analyses were carried out using contingency tables, the Chi-square test, and Cramer’s V statistics. The sample was also segmented based on key variables. Finally, the results were analyzed using logistic regression. In the sample population, 62.5% had taken the fecal occult blood test (FOBT), 72.5% reported receiving the invitation letter to participate in the screening program, and 86.8% had prior knowledge of the FOBT. Noncompliance was mainly due to lack of symptoms (40%), non-receipt of invitation letters (39.7%), and forgetfulness or neglect (28.5%). On the contrary, receipt of the letter of invitation (OR 7.35, p < 0.01) and prior knowledge of FOBT (OR 6.32, p < 0.01) were the main variables that increased the probability of test uptake. Other significant variables included frequency of primary care visits (OR 1.71, p < 0.01) and being older (65–69 years old) (OR 1.52, p < 0.01) There is still a pressing need for greater awareness of both CRC risk factors and the benefits of early detection, as well as for overcoming the common misconception that detection should only be sought when symptoms are present.